Form 4: Verastem Director Kapur Receives Stock Options and Restricted Stock Units

Director Anil Kapur receives stock options and restricted stock units in Verastem, Inc.

Summary

• On June 18, 2024, Anil Kapur, a director of Verastem, Inc., was granted 8,333 restricted stock units (RSUs) and an option to purchase 12,500 shares of common stock.
• The RSUs vest in twelve equal monthly installments from June 2024 to April 2025, with the final installment vesting on the earlier of the day before the 2025 Annual Meeting of Stockholders or May 31, 2025, contingent upon continued service as a director.
• The stock option, with an exercise price of $3.27, also vests in twelve equal monthly installments from June 2024 to April 2025, with the final installment vesting on the earlier of the day before the 2025 Annual Meeting of Stockholders or May 31, 2025, contingent upon continued service as a director.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard compensation practices that align director interests with shareholder value. The vesting schedule promotes long-term commitment.

Positives

• The grant of RSUs and stock options to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's success.
• The vesting schedule encourages continued service and commitment from the director.

Industry Context

Stock options and restricted stock units are common forms of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders and incentivizing long-term value creation.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors in publicly traded companies, particularly in the biotech sector.
• Companies like Amgen, Gilead Sciences, and Biogen routinely use stock options and RSUs to incentivize their directors and key employees.
• The vesting schedules described are typical, designed to retain talent and align interests over a multi-year period.

Stakeholder Impact

• Shareholders may view the granting of stock options and RSUs positively, as it aligns the director's interests with the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to incentivizing its leadership.

Key Dates